Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2013 by University of Debrecen.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Semmelweis University
Information provided by (Responsible Party):
Attila Vajas, University of Debrecen
ClinicalTrials.gov Identifier:
NCT00931125
First received: July 1, 2009
Last updated: October 14, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)